Asset Details
Do you wish to reserve the book?
Unique volatolomic signatures of TP53 and KRAS in lung cells
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Unique volatolomic signatures of TP53 and KRAS in lung cells
Do you wish to request the book?
Unique volatolomic signatures of TP53 and KRAS in lung cells
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Unique volatolomic signatures of TP53 and KRAS in lung cells
2014
Overview
Background:
Volatile organic compounds (VOCs) are potential biomarkers for cancer detection in breath, but it is unclear if they reflect specific mutations. To test this, we have compared human bronchial epithelial cell (HBEC) cell lines carrying the KRAS
V12
mutation, knockdown of TP53 or both with parental HBEC cells.
Methods:
VOC from headspace above cultured cells were collected by passive sampling and analysed by thermal desorption gas chromatography mass spectrometry (TD-GC–MS) or sensor array with discriminant factor analysis (DFA).
Results:
In TD-GC–MS analysis, individual compounds had limited ability to discriminate between cell lines, but by applying DFA analysis combinations of 20 VOCs successfully discriminated between all cell types (accuracies 80–100%, with leave-one-out cross validation). Sensor array detection DFA demonstrated the ability to discriminate samples based on their cell type for all comparisons with accuracies varying between 77% and 93%.
Conclusions:
Our results demonstrate that minimal genetic changes in bronchial airway cells lead to detectable differences in levels of specific VOCs identified by TD-GC–MS or of patterns of VOCs identified by sensor array output. From the clinical aspect, these results suggest the possibility of breath analysis for detection of minimal genetic changes for earlier diagnosis or for genetic typing of lung cancers.
Publisher
Nature Publishing Group UK,Nature Publishing Group
Subject
/ 692/53
/ Biomedical and Life Sciences
/ Bronchi
/ Epithelial Cells - metabolism
/ Gas Chromatography-Mass Spectrometry
/ Genomes
/ Humans
/ Kinases
/ Medicine
/ Mutation
/ Oncology
/ Proto-Oncogene Proteins - genetics
/ Proto-Oncogene Proteins p21(ras)
/ Sensors
/ Tumor Suppressor Protein p53 - genetics
/ VOCs
